Dr. Robert Ryder revealed his research with a new reversible non-surgical weight loss system called the EndoBarrier
Mid-September 2017, Portugal, at the yearly gathering of the European Association for the Study of Diabetes (EASD) Dr. Robert Ryder chief investigator for the Association of British Clinical Diabetologists’ revealed his research with a new reversible non-surgical weight loss system called the EndoBarrier. In Great Briton the term for Type 2 diabetic patients who are also very overweight is “diabesity.”
Ryders’ study indicates that this new device, a “sleeve” implanted in the small intestine under anesthesia, is both safe and effective. It could be utilized by the NHS – British National Health Service – soon. The goal is to provide a safe non-surgical weight loss system similar to gastric bypass, but in a reversible option; especially for diabetics. Unlike gastric bypass, this device can be removed after a year with no damage; plus it is cheaper and much less invasive for the patient than the bypass procedure. The sleeve-like device is 60 centimeters in length and stops food absorption in the first section of the small intestine. While not yet available in the US, the manufacturer, GI Dynamics Inc. out of Boston say it can only be used investigationaly here in the states.
in October 2014 Ryder opened a clinic in City Hospital in Birmingham in a large trial to prove its’ effectiveness. They selected 60 very difficult to treat Type 2 diabetic patients. The average person selected had lived with diabetes for 13 years and 17 of them were on insulin. They were also instructed on diet, exercise and lifestyle changes.